Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials

References

• Carmeli Y. Strategies for managing today’s infections. Clin Microbiol Infect 2008;14(Suppl. 3):22-31
   PubMed Web of Science ®Google Scholar
• Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005;11(Suppl. 4):17-32
   PubMed Web of Science ®Google Scholar
• Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003;16:135-43
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12
   PubMed Web of Science ®Google Scholar
• Infectious Diseases Society of America. Bad Bugs, No Drugs As Antibiotic Discovery Stagnates … A Public Health Crisis Brews. Alexandria, VA: Infectious Diseases Society of America, 2004
   Google Scholar
• Zhanel GG, DeCorby M, Laing N, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 2008;52:1430-7
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:3352-9
   PubMed Web of Science ®Google Scholar
• Kollef MH Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31(Suppl. 4): S131-S138
   PubMed Web of Science ®Google Scholar
• Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55
   PubMed Web of Science ®Google Scholar
• Fritsche TR, Stilwell MG, Jones RN Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). Clin Microbiol Infect 2005;11:974-84
   PubMed Web of Science ®Google Scholar
• Ge Y, Wikler MA, Sahm DF, et al. In vitro antimicrobial activity of doripenem, a new carbapenem. Antimicrob Agents Chemother 2004;48:1384-96
   PubMed Web of Science ®Google Scholar
• Jones RN, Huynh HK, Biedenbach DJ Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrob Agents Chemother 2004;48:3136-40
   PubMed Web of Science ®Google Scholar
• Wexler HM, Engel AE, Glass D, et al. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Antimicrob Agents Chemother 2005;49:4413-17
   PubMed Web of Science ®Google Scholar
• Lister PD Carbapenems in the USA: focus on doripenem. Expert Rev Anti Infect Ther 2007;5:793-809
   PubMed Web of Science ®Google Scholar
• Nicolau DP Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother 2008;9:23-37
   PubMed Web of Science ®Google Scholar
• Pillar CM, Torres MK, Brown NP, et al. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States. Antimicrob Agents Chemother 2008;52:4388-99
   PubMed Web of Science ®Google Scholar
• Lucasti C, Jasovich A, Umeh O, et al. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clin Ther 2008;30:868-83
   PubMed Web of Science ®Google Scholar
• Malafaia O, Umeh O, Jiang J, et al. Doripenem versus meropenem for the treatment of complicated intra-abdominal infections. Presented at: 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Sept. 27–30, 2006, San Francisco, CA
   Google Scholar
• Rea-Neto A, Niederman M, Lobo SM, et al. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Curr Med Res Opin 2008;24:2113-26
   PubMed Web of Science ®Google Scholar
• Chastre J, Wunderink R, Prokocimer P, et al. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med 2008;36:1089-96
   PubMed Web of Science ®Google Scholar
• Doribax® (doripenem for injection) package insert. Ortho-McNeil Pharmaceuticals, Inc., Raritan, NJ, 2009
   Google Scholar
• Primaxin® IV (imipenem and cilastatin for injection) package insert. Merck & Co., Inc., Whitehouse Station, NJ, 2009
   Google Scholar
• Levaquin® (levofloxacin) package insert. Ortho-McNeil Pharmaceuticals, Inc., Raritan, NJ, 2008
   Google Scholar
• Merrem® (meropenem for injection) package insert. AstraZeneca Pharmaceuticals, Inc., Wilmington, DE, 2007
   Google Scholar
• Zosyn® (piperacillin/tazobactam for injection) package insert. Wyeth Pharmaceuticals Inc., Philadelphia, PA, 2007
   Google Scholar
• SAS Institute Inc. SAS/STAT User’s Guide. SAS Institute Inc., Cary, NC, 1999
   Google Scholar
• Fleiss JL, Levin B, Paik MC. Combining evidence from fourfold tables. In: Fleiss JL, Levin B, Paik MC (eds). Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons, Inc., 2003:234-83
   Google Scholar
• Merchant S, Gast C, Nathwani D, et al. Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Clin Ther 2008;30:717-33
   PubMed Web of Science ®Google Scholar
• Kollef KE, Schramm GE, Wills AR, et al. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008;134:281-7
   PubMed Web of Science ®Google Scholar